Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3119271000168119 | Mabcampath (alemtuzumab 30 mg / 1 mL) injection, 1 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3119281000168116 | Mabcampath 30 mg/mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Mabcampath 30 mg/mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
Mabcampath 30 mg/mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 2143166287 | |
Mabcampath 30 mg/mL injection, vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Mabcampath 30 mg/mL injection, vial | Is a | Mabcampath | true | Inferred relationship | Some | ||
Mabcampath 30 mg/mL injection, vial | Is a | alemtuzumab 30 mg/mL injection, vial | true | Inferred relationship | Some | ||
Mabcampath 30 mg/mL injection, vial | has manufactured dose form | intravenous infusion injection | false | Inferred relationship | Some | ||
Mabcampath 30 mg/mL injection, vial | has Australian BoSS | alemtuzumab | true | Inferred relationship | Some | 2143166286 | |
Mabcampath 30 mg/mL injection, vial | has intended active ingredient | alemtuzumab | true | Inferred relationship | Some | 2143166286 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Mabcampath 30 mg/mL injection, 3 x 1 mL vials | has TPUU | True | Mabcampath 30 mg/mL injection, vial | Inferred relationship | Some | 1 |
Mabcampath 30 mg/mL injection, 3 x 1 mL vials | has TPUU | True | Mabcampath 30 mg/mL injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Australian dialect reference set
Trade product unit of use reference set